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Background: Assessing left ventricular (LV) dysfunction by echocardiography in ICU patients is common. The aim
of this study was to investigate mitral annular plane systolic excursion (MAPSE) in critically ill patients with shock
and its relation to LV systolic and diastolic function, myocardial injury and to outcome.
Methods: In a prospective, observational, cohort study we enrolled 50 patients with SIRS and shock despite fluid
resuscitation. Transthoracic echocardiography (TTE) measuring LV function was performed within 12 hours after
admission and daily for a 7-day observation period. TTE and laboratory measurements were related to 28-day mortality.
Results: MAPSE on day 1 correlated significantly with LV ejection fraction (LVEF), tissue Doppler indices of LV diastolic
function (é, E/é) and high-sensitive troponin T (hsTNT) (p< 0.001, p= 0.039, p= 0.009, p= 0.003 respectively) whereas
LVEF did not correlate significantly with any marker of LV diastolic function or myocardial injury. Compared to survivors,
non-survivors had a significantly lower MAPSE (8 [IQR 7.5-11] versus 11 [IQR 8.9-13] mm; p= 0.028). Other univariate
predictors were age (p=0.033), hsTNT (p=0.014) and Sequential Organ Failure Assessment (SOFA) scores (p=0.007). By
multivariate analysis MAPSE (OR 0.6 (95% CI 0.5- 0.9), p= 0.015) and SOFA score (OR 1.6 (95% CI 1.1- 2.3), p= 0.018) were
identified as independent predictors of mortality. Daily measurements showed that MAPSE, as sole echocardiographic
marker, was significantly lower in most days in non-survivors (p<0.05 at day 1–2, 4–6).
Conclusions: MAPSE seemed to reflect LV systolic and diastolic function as well as myocardial injury in critically ill
patients with shock. The combination of MAPSE and SOFA added to the predictive value for 28-day mortality.
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In intensive care patients a frequently applied method
for estimating LV systolic function is left ventricular
ejection fraction (LVEF) [1]. LV systolic dysfunction has
been observed in critically ill patients with shock [2,3]
although there is conflicting evidence that LV systolic
impairment is associated with mortality [2,4,5].
Mitral annular plane systolic excursion (MAPSE) also
known as left atrioventricular plane displacement (AVPD),
mitral annulus excursion (MAE) or mitral ring displace-
ment is an M-mode derived echocardiographic marker of
LV longitudinal function [6-8]. MAPSE correlates well* Correspondence: lill.bergenzaun@skane.se
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distribution, and reproduction in any mediumwith other markers of LV function [6,9,10], is easily ob-
tainable [11-13] even for the untrained observer [12] and
in patients with poor acoustic windows [8]. It has been
suggested as a surrogate measurement for LVEF in cardiac
patients [12,14]. A reduced MAPSE has been shown to
correlate with age, and LV function in patients with
myocardial infarction, heart failure and atrial fibrillation
[15-17] and to be more sensitive than conventional echo-
cardiographic markers in detecting abnormalities in LV
systolic function at an early stage [7,18]. MAPSE is known
to be prognostic for major cardiac events and mortality in
patients with cardiovascular disease [15,19-21]. In critic-
ally ill patients there are no reports of the use of MAPSE,
its association with other echocardiographic parameters,
myocardial injury or clinical outcome.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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prognostic significance in critically ill patients with shock.
Further, we wanted to examine if MAPSE correlates with
other markers of LV function and myocardial injury.
Material and methods
The study was approved by the Regional Ethics Review
Board, Lund, Sweden (Dnr.187/2005). Informed consent
was sought from the patient or, if not possible, from the
next of kin. The study design was a prospective obser-
vational cohort study. Patients >18 years old admitted to
the mixed-bed ICU of Skåne University Hospital, Malmö,
Sweden, were screened for eligibility. We included 55 con-
secutive patients with Systemic Inflammatory Response
Syndrome (SIRS) and concurrent shock, where shock was
defined as failure to maintain mean arterial pressure ≥ 70
mmHg, despite adequate fluid resuscitation according to
the surviving sepsis campaign algorithm [22]. Exclusion
criteria were pregnancy, known abnormalities of coagula-
tion, fibrinolytic therapy, compromised immunity or a
“Do Not Attempt Resuscitation” order. Acute Physiology
and Chronic Health Evaluation (APACHE) II scores [23]
were calculated at admission and Sequential Organ Failure
Assessment (SOFA) scores [24] were calculated daily.
After the initial resuscitation period, fluids were given at
the treating clinician’s discretion. Mean arterial pressure
(MAP), heart rate (HR), positive end expiratory pres-
sure (PEEP) and vasopressor (norepinephrine) dose was
recorded at the time of the TTE examination. Blood sam-
ples were taken from an indwelling arterial line within 12
h of inclusion. High-sensitive troponin T (hsTNT) and B-
natriuretic peptide (BNP) were analyzed as reported previ-
ously [25]. Patients were followed for 7 days or until dis-
charge from ICU. Mortality was defined as 28-day all
cause mortality.
Transthoracic echocardiography
Transthoracic echochardiography (TTE) was performed
within 12 hours after admission and daily for a 7-day ob-
servation period or until discharge from ICU by one of
four experienced echocardiographers (LB, MC, PG, MD).
Images were acquired using a Hewlett- Packard Sonos
5500 (Andover, Mass, U.S.A) scanner and a 3 MHz trans-
ducer. Two-dimensional (2D) imaging examinations were
performed in the standard apical four- and two- chamber
views (2C- and 4C views). Tissue harmonic imaging was
used to enhance 2D image quality. LV ejection fraction
(LVEF) was assessed by visual estimation of EF, based on
“eyeball” ejection fraction. M-mode images were obtained
at the LV septal, lateral, anterior, and posterior borders of
the mitral ring [18] in the apical 2C- and 4C views, and an
average mitral annular plane systolic excursion (MAPSE)
value was calculated. Pulsed-wave (PW) tissue Doppler
recorded the peak systolic velocity (TDIs) of the LV septalwall at the level of the mitral annulus in the apical 4C view
[26]. Transmitral velocities were measured with PW Dop-
pler in the 4C view. For LV diastolic function, we used the
mitral inflow profile, the E- and A-velocity and calculated
the E/A ratio. PW tissue Doppler recorded the diastolic
velocities (é) of the LV septal wall at the level of the mitral
annulus in the apical 4C view. The E/é ratio, an index of
LV filling pressure, was calculated and é (septal) < 8cm/s
indicated diastolic dysfunction [27]. All TTE studies were
recorded over three consecutive cardiac cycles independ-
ently of the respiratory cycle and averaged. In patients
with non-sinus rhythm measurements were collected over
5–10 heartbeats. Analyses of the measurements were
made in Phillips digital storing and analysis software
Xcelera (Best, the Netherlands) offline.
Statistical analysis
Data are presented as median (lower quartile: upper quar-
tile), percentages or absolute values. For not normally dis-
tributed variables we used non-parametric test exclusively.
For correlation between two variables, Spearman’s rank
correlation was used and for differences between two
groups we used Mann-Whitney’s U-test. Categorical data
were analyzed with Fisher’s exact test. HsTNT and BNP
were log transformed with natural logarithm due to skewed
distribution. Discrimination analysis was performed using
receiver operating characteristics (ROC) curve under the
area using multiple logistic regression predictions. Our aim
was to investigate how 28-day mortality can be predicted
by more than one explanatory variable measured early dur-
ing ICU stay. Since we did not have any censored data
during this period and odds ratio was the outcome of inter-
est, logistic regression was chosen to be the most suitable
method [28]. Multivariate (backward stepwise selection
method with probability for the removal of 0.10) logistic
regression analyses were used to determine the associa-
tion of variables with 28-day mortality. The Hosmer and
Lemeshow test of goodness of fit was used to indicate if the
model provides an adequate fit to the data. Odds ratios
(OR) were calculated. We have used the method described
by Hoaglin and Iglewicz [29] to test for outliers. The intra-
and inter-observer variability of echocardiographic parame-
ters was measured by the coefficient of variation (CV). CV
was defined as the ratio of the standard deviation to the
mean multiplied by 100. All probability values are two-
tailed and significance was set at p < 0.05. The analyses
were performed using SPSS 18.0 (SPSS, Chicago, IL, U.S.).
Results
Patient characteristics
The original study included 55 consecutive patients.
Two patients were excluded due to lack of written
consent. In two patients TTE examinations were not
recorded (death before possible TTE and morbid obesity
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in the echocardiography database. These five patients were
excluded resulting in a total of 50 analyzed patients. Of
350 expected echocardiographic examinations, 96 were
missing because of death or discharge from the ICU
before Day 7. Another 23 examinations were lost during
the installation of a new offline storing and analysis sys-
tem. Thus, in total, 231 examinations were available for
analysis. An additional file shows this in more detail see
(Additional file 1). Two-thirds of the population suffered
from septic shock and one-third from shock due to otherTable 1 Baseline and echocardiographic characteristics of stu
All n=50 S
Clincal data
Median age, y 65 (54–74) 6
Female sex, n (%) 14 (28)
Diabetes mellitus, n (%) 6 (12)
Hypertension, n (%) 12 (24)
Cardiac disease, n (%) 12 (24)
APACHE II score 24 (19–29)
SOFA score 12 (9–14)
HR, beats/min 99 (85–115)
MAP, mmHg 76 (70–88)
NE dose, μg/kg/min 0.09 (0.05-0.14) 0
CRRT, n (%) 14 (28)
Fluids, ml/kg/24h 43 (22–84)
Mechanical ventilation, n (%) 45 (90)
Peep, cmH2O 8 (5–10)
Biochemical data
Creatinine, μmol/L 156 (94–243)
Lactate mmol/L 2.2 (1.6-3.2)
hsTNT, ng/L 79.5 (23–182) 7
BNP, pmol/L 187 (98–375)
Echocardiographic data n=47
LVEF, % 49 (40:55)
LVEF, %, mean (±SD) 47 (±14.8)
MAPSE, mm 10 (8.0-12.6)
MAPSE, mm, mean (±SD) 10.3 (±2.8)
TDIs cm/s 8.9 (7.1-10.0)
E/A 1.2 (0.9-1.5)
é, cm/s 8.3 (7–10)
é, cm/s, mean (±SD) 8.7 (±2.2)
E/é 10.2 (8.5–12)
E/é, mean (±SD) 10.7 (±3.7)
Data are presented as median (lower quartile- upper quartile), as mean (± SD) or in
CRRT (Continuous Renal Replacement Therapy), SOFA (Sequential Organ Failure Ass
Peep (positive end expiratory pressure).causes (pancreatitis, post-major non-cardiac surgery, in-
toxication and multiorgan failure, gastrointestinal bleeding
and portal hypertension or unknown cause). Pre-existing
cardiac disease was present in 12 (24%) patients defined as
severe arrhythmia, heart failure or ischemic heart disease.
Forty-five (90%) patients were mechanically ventilated at
inclusion. Acute kidney failure was present in 14 (28%) pa-
tients requiring continuous renal replacement therapy
(CRRT), including one patient with chronic kidney failure
(Table 1). Twelve patients (24%) received dobutamine and
one (2%) adrenaline at inclusion. The median ICU lengthdied patients at day 1
urvivors n=37 Non-survivors n=13 p
0.5 (49.5–72.0) 72.0 (69.0–76.0) 0.033
12 (32) 2 (15) >0.1
5 (14) 1 (8) >0.1
11 (30) 1 (8) >0.1
8 (22) 4 (31) >0.1
24 (17–28) 28 (21–34) 0.060
10 (9–13) 13 (13–14) 0.007
99 (85–116) 98 (83–107) >0.1
76 (70–90) 76 (73–79) >0.1
.08 (0.04-0.13) 0.1 (0.09-0.18) >0.1
11 (30) 3 (23) >0.1
38 (20–81) 46 (28–77) >0.1
35 (95) 10 (77) >0.1
8 (5–10) 10 (9–13) 0.083
138 (86–221) 182 (118–246) >0.1
2.2 (1.6-3.2) 2.6 (1.8-4.6) >0.1
7.5 (18.6-125.3) 152 (80–501) 0.014
157 (84–356) 262 (183–440) >0.1
n=34 n=13
50 (40–50) 45 (35–65) >0.1
47 (±12.8) 48 (±19.7)
11 (8.9-13) 8 (7.5-11) 0.028
10.9 (±2.9) 8.7 (±2.5)
8.9 (7.2-9.9) 7.5 (6.6-10) >0.1
1.2 (0.9-1.5) 1.3 (0.9-1.6) >0.1
8.4 (7.5-10.5) 7.2 (6.3-8.6) >0.1
8.9 (±2.0) 8.0 (±2.6)
10.0 (8.2–11.5) 13.0 (9.6–15.2) 0.055
9.8 (±2.8) 12.7 (±5.0)
numbers (%). APACHE II (Acute Physiology and Chronic Health Evaluation),
essment), HR (heart rate), MAP (mean arterial pressure), NE (norepinephrine),
Table 3 Multivariate analysis for predictors of death in
patients with shock
Multivariate analysis
Odds Ratio (95%CI) Wald statistics p
MAPSE (mm) 0.666 (0.5-0.9) 5.915 0.015
SOFA score 1.596 (1.1-2.3) 5.638 0.018
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seven days and thirteen patients after 28 days with an all
cause 28-day mortality of 26%.
Mitral annular plane systolic excursion (MAPSE) and
relation to other echocardiographic parameters
On day 1 a total of 47 echocardiographic examinations
were available for analysis, since 3 examinations were lost
during the installation of a new offline storing and analysis
system. Results on day 1 showed that MAPSE was signifi-
cantly lower in non-survivors (median 8 [IQR 7.5-11]
mm) than in survivors (median 11 [IQR 8.9-13] mm) of
28-day mortality (p= 0.028). No other echocardiograohic
parameter showed any significant difference (Table 1). In
14 (30%) patients ejection fraction was preserved (LVEF ≥
55%) and in 33 patients (70%) impaired (LVEF ≤ 50%)
with no significant difference in mortality between these
two groups. Six patients had severely reduced LV systolic
function (LVEF < 30%). MAPSE was 11 [11–12.8] mm in
patients with preserved EF and 9 [7.3-12.3] mm in those
with reduced EF (p= 0.069). MAPSE correlated signifi-
cantly with LVEF, é, E/é and hsTnT whereas LVEF did not
correlate significantly with markers of LV diastolic func-
tion, filling pressure or cardiac biomarkers (Table 2).
MAPSE showed a negative correlation with age (r=−0.411,
p=0.003) but was not associated with previous hyper-
tension or cardiac disease. LV diastolic dysfunction (é <
8 cm/s) showed a significant negative association with
MAPSE (p= 0.047) whereas there was none with LVEF.
The intra- and inter-observer variability for MAPSE
was 4.4% and 5.3% respectively, and for other echocar-
diographic markers as reported previously [13,25].
Mortality
MAPSE (p= 0.028), SOFA score (p= 0.007), age (p= 0.033)
and hsTNT (p= 0.014) were identified as univariate pre-
dictors of 28-day mortality (Table 3). A multivariate logis-
tic regression analysis including these variables identifiedTable 2 Correlation (r) between markers of LV systolic
function with LV diastolic function and cardiac
biomarkers
MAPSE TDIs LVEF
r p r p r p
LV systolic function
LVEF 0.594 <0.001 0.649 <0.001
LV diastolic function
é 0.309 0.039 0.341 0.022 ns
E/é -0.383 0.009 ns ns
Cardiac biomarkers
hsTNT -0.428 0.003 ns ns
BNP ns ns ns
Spearman rank correlation was used. Statistical significance at p< 0.05.a model with MAPSE (p= 0.015) and SOFA (p= 0.018) as
independent predictors of 28-day mortality. The Hosmer
and Lemeshow test for the model was non-significant
(p=0.998) indicating adequate fit to the data. The adjusted
OR for MAPSE and SOFA score were 0.6 (95% CI 0.5-
0.9) and 1.6 (95% CI 1.1- 2.3) respectively (Table 3). With
regards to 28-day mortality the area under the curve (AUC)
at day 1 for MAPSE was 0.709 (95% CI 0.548- 0.870, p =
0.028) with 69% sensitivity and 68% specificity for a cut-off
value of 8 mm and AUC for SOFA score was 0.733 (95%
CI 0.592- 0.874, p = 0.014) with 69% sensitivity and 68%
specificity for a cut-off value of 12. When adding MAPSE
to SOFA score, the AUC for the combined predictor in-
creased to 0.831 (95% CI 0.711- 0.952, p <0.001) (Figure 1).Cardiac biomarkers
Results at day 1 showed that hsTNT was significantly
higher in non-survivors (152 [IQR 80–501] ng/L) than in
survivors (77.5 [IQR 18.6-125.3] ng/L) (p= 0.014) whereas
there was no difference in BNP (Table 1). In patients with
diastolic dysfunction (é< 8cm/s) both hsTNT and BNP
were significantly higher in non-survivors compared to
survivors (p= 0.020 and p= 0.039 respectively); this was
not seen in those with systolic dysfunction (LVEF≤ 50%).
hsTNT showed a significant negative correlation with
MAPSE but not with LVEF or TDIs (Table 3). In patients
with diastolic dysfunction (é< 8cm/s) hsTNT and BNP
showed a significant negative correlation with MAPSE
(r= −0.478, p= 0.033; borderline for BNP r= −0.441, p=
0.051) but there was none with TDIs.
Daily measurements over 7 days showed that in non-
survivors MAPSE was significantly lower in most days
(day 1 p=0.028, day 2 p=0.003, day 3 p=0.060, day 4
p= 0.036, day 5 p=0.026, day 6 p=0.017, day 7 p=0.075)
(Figure 2) whereas LVEF was not significant different
(p>0.1) at any day (Figure 3).Discussion
Our main findings are that MAPSE was an independent
predictor of 28-day mortality in critically ill patients with
shock and systemic inflammation. Combining MAPSE
with SOFA increased the predictive value for mortality.
MAPSE correlated with markers of LV systolic and dia-




















Figure 1 Receiver operating characteristic (ROC) for MAPSE and
for a combined predictor consisting of MAPSE and SOFA score.
With regards to 28-day mortality the area under the curve (AUC) for
MAPSE was 0.709 (95% CI 0.548- 0.870, p= 0.028) and for the























Figure 2 Boxplots of daily measurements show that MAPSE is
significantly lower in non-survivors (grey) of 28-day mortality
compared to survivors (white) in most days (day 1 p=0.028,
day 2 p=0.003, day 3 p=0.060, day 4 p= 0.036, day 5 p=0.026,
day 6 p=0.017, day 7 p=0.075). ° Value and case number within






















Figure 3 Boxplots of daily measurements show that there is
no significant difference (p>0.1) at any day in LVEF between
survivors (white) and non-survivors (grey) of 28-day mortality.
° Value and case number within 1.5 boxplot length (SPSS 18.0).
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In critically ill patients echocardiography has gained popu-
larity as a tool for assessing LV function [5,30]. LVEF is
probably the most commonly used and accepted method
of measuring LV systolic function in this setting [1] how-
ever its usefulness in predicting mortality has produced
conflicting results [2,5,31]. In patients with septic shock
studies measuring the LV longitudinal function by tissue
Doppler imaging (TDI) have moved into focus during the
recent years identifying mainly diastolic TDI indices as
prognostic markers whereas systolic TDI parameters seem
to be less consistently related to mortality [31-34]. Inter-
estingly in none of these studies MAPSE was used as a
marker of LV systolic function.
MAPSE is a simple, easily obtained parameter and
may contribute to the evaluation of systolic function.
MAPSE was obtainable in all patients, and showed inter-
and intra-observer variability of 4.4% and 5.3% [13]. It is
less well investigated than its right ventricular counter-
part, tricuspid annular plane systolic excursion (TAPSE),
and has received considerably less attention than TDI
variables. In critical care settings where acoustic win-
dows are often suboptimal, MAPSE seems to be an at-
tractive parameter. A decreased MAPSE is known to be
associated with conditions affecting LV function such as
myocardial infarction, heart failure, atrial fibrillation and
age [15-17] and its relation to mortality has been de-
scribed by several studies in patients with cardiovascular
disease [15,19-21].
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in non-survivors compared to survivors and could to-
gether with SOFA score be identified as independent pre-
dictors of 28-day mortality. Further, combining MAPSE
and SOFA score seemed to increase the risk of death.
These results are strengthened by the finding that MAPSE
was significantly decreased in non-survivors compared to
survivors in most days of the 7-day observation whereas
LVEF was not. LVEF, on the other hand, being near nor-
mal could not be identified as a prognostic marker and
we speculate if this, like in patients with cardiovascular
disease and preserved ejection fraction, could be due to
LVEF being less sensitive in uncovering subtle myocardial
changes [35,36].MAPSE in relation to other markers of LV function and
myocardial injury
Previous studies in patients with cardiovascular disease
have suggested MAPSE as a surrogate measurement for
LVEF with both normal and reduced LV function [12,14].
A mean value for MAPSE of > 10 mm was linked with
preserved EF (≥ 55%) and values < 8 mm with reduced EF
(< 50%) [6,19,37]. Our results are in line with this, with
MAPSE correlating significantly with LVEF. MAPSE was
11 [11–12.8] mm in patients preserved EF and in those
with reduced EF slightly higher than 8 mm (MAPSE 9
[7.3-12.3] mm).
Although MAPSE and LVEF may be related, they are
not entirely interchangeable [13,17]. MAPSE is sug-
gested to be primarily representative of subendocardial,
longitudinally oriented, myocardial fibres compared to
the subepicardial, circumferential fibres measured by
LVEF, and is known to detect more subtle abnormalities
of LV function [7,18]. This is seen in patients with in-
creasing age, myocardial hypertrophy or diastolic dysfunc-
tion with preserved ejection fraction (HFpEF) where
long axis function of the heart is already impaired while
the radial function can be preserved or even increased
[18,35]. Thus by using LVEF the long axis function of
the heart is not necessarily considered.
Similar to MAPSE, tissue Doppler imaging is de-
scribed to be superior to conventional echocardiography
in detecting abnormalities of LV function [38] and its
correlation with MAPSE has been described previously
[39]. In a recent study (Wenzelburger), TDI indices of
both LV diastolic and systolic function correlated sig-
nificantly with MAPSE in patients with HFpEF [35] il-
lustrating the close relationship between systolic and
diastolic LV function. LV systolic torsional (twisting) de-
formation is one mechanism by which potential energy
is stored. After systole the heart relaxes or untwists, an
energy releasing process, and aids to early LV filling by
suctioning [40]. Thus a decrease in atrioventricualarplane motion will result in less energy stored during sys-
tole and hence reduced LV diastolic mechanics.
The relationship between MAPSE and TDI indices is
supported by our results where MAPSE correlated signifi-
cantly with é, a diastolic marker, and showed a negative
significant correlation with E/é, a surrogate marker for
LV filling pressure. Additionally we found a significant as-
sociation between diastolic dysfunction (é< 8cm/s) and
MAPSE, but none with LVEF. Of note, in our previous
study we showed a significant correlation between MAPSE
and the systolic marker of tissue Doppler imaging (TDIs)
(r= 0.427, p< 0.01) [13].
Notably, MAPSE and TDI are not interchangeable.
The two parameters describe different vector compo-
nents of longitudinal systolic motion. Although TDIs has
been described to correlate well with MAPSE in studies
with healthy individuals [39,41], they differ in some im-
portant aspects [42] as MAPSE measures the entire sys-
tolic phase including isovolumetric contraction [15] in
contrast to TDIs. In addition a blurred TDI signal can
be a confounding factor when measuring the velocity
[43] and in these situations MAPSE can be a valuable.
Overall we believe that MAPSE and tissue Doppler mea-
surements are important echocardiographic parameters
in assessing LV function.
Finally, we sought to investigate if there was a relation-
ship between cardiac biomarkers (hsTNT and BNP) and
MAPSE and found that hsTNT but not BNP was signifi-
cantly higher in non-survivors and correlated signifi-
cantly with MAPSE but not LVEF. This is in line with a
recent study in septic neonates were hsTNT was signifi-
cantly higher in non-survivors and correlated with longi-
tudinal LV systolic function measured by TDI but not
with fractional shortening [44]. Landesberg et al. [32]
found that hsTNT was significantly higher in patients
with decreased é and LVEF. This is similar to our find-
ings where hsTNT in patients with diastolic dysfunction
showed a significant negative correlation with MAPSE.
Although we found no relationship between LVEF and
cardiac troponin T our findings are generally in support
of these studies and we speculate if MAPSE may be
more sensitive than LVEF in detecting early myocardial
changes in critically ill patients with shock.
Limitations
Firstly, we used eyeballing to measure LVEF. Simpson’s bi-
plane method is the currently accepted standard. We and
others have previously shown that eyeball EF was as good
as the Simpson’s method [13,45], and was more easily
obtained in ICU patients [13]. Although unlikely, we can-
not exclude that using Simpson’s method for measuring
LVEF could have influenced our results. Secondary ana-
lysis (data not shown) in 44 patients where good-quality
Simpson’s EF could be obtained showed no relationship
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for specific conditions affecting MAPSE measurements
such as localized wall motion abnormalities or mitral an-
nular calcifications. Thirdly, no dynamic fluid responsive-
ness tests were used limiting our results, as MAPSE in
analogy with tissue Doppler measurements, is affected by
changing fluid conditions. Finally, the multivariate analysis
was limited by the small number of patients in this study,
and we cannot exclude other confounding factors. Never-
theless, we clearly demonstrate a relationship between
MAPSE and 28-day mortality.
Conclusions
In this study we showed that MAPSE but not LVEF cor-
related with other markers of LV function and myocar-
dial injury and could be identified as an independent
predictor of 28-day mortality. Its predictive value in-
creased when added to SOFA score. A reduced MAPSE
persisted in non-survivors throughout the ICU stay. Fu-
ture prospective studies should evaluate the advantages
and weaknesses of MAPSE in critically ill patients with
shock where vasoactive drugs and positive pressure ven-
tilation are commonly used, all influencing echocardio-
graphic measurements.
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